GCDPipe: risk gene, cell type, and drug ranking for complex traits
Daria V. PinakhinaiD, Alexander A. LobodaiD, Alexey SergushicheviD, Mykyta ArtomoviD
Abstract
We introduce a user-friendly machine learning tool for risk gene, cell type, and drug ranking for complex traits - GCDPipe. It uses gene-level GWAS-derived data and publicly available expression data to train a model for prediction of disease risk genes and relevant cell types. Gene-ranking information is then coupled with known drug targets data to prioritize drugs based on their estimated functional effects associated with identified risk genes. The pipeline was tested in two case studies: inflammatory bowel disease (IBD) and schizophrenia, then it was applied to Alzheimers disease to investigate potential options for drug repurposing. The results show that GCDPipe is an effective tool to unify genetic risk factors with cellular context and known drug targets.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The Gene Expression Landscape of Disease Genes
Judit García‐González, Alanna C. Cote, … Paul F. O’Reilly·Genome biologyPeer-reviewed·Feb 9, 2026
- Linking Genetic Risk to Disease-Relevant Cellular States via Metacell-Informed Modeling with ICePop
Hao Yuan, Aishwarya Mandava, … Arjun Krishnan·bioRxiv·May 15, 2026
- Novel joint enrichment test demonstrates high performance in simulations and identifies cell-types with enriched expression of inflammatory bowel disease risk loci
Alexandru-Ioan Voda, Luke Jostins-Dean·bioRxiv·Jun 13, 2023
- GenesetDiseaseDrugNetwork (GDDN): a web server for disease enrichment and drug prioritization
Piyush A. More, Jean−Fred Fontaine, … Miguel Angel Andrade-Navarro·bioRxiv·May 26, 2026
- drugMR: A multi-omics pipeline for genetically anchored drug-target discovery
Guillermo Comesana Cimadevila, Marie‐Joe Dib, … Valentina Escott‐Price·bioRxiv·Oct 8, 2026
- Integration of genetic evidence to identify approved drug targets
Samuel Moix, Marie C. Sadler, Zoltán Kutalik·Genome MedicinePeer-reviewed·Jul 6, 2026